Optimising biological activity and ADME properties, while minimising toxicity, are objectives when developing new compounds. Advanced machine learning is indispensable to this process. The AiChemist develops and benchmarks representation learning approaches, addressing their accuracy and explainability, using public and in-house data. We will also organise QSAR2027. Follow us on LinkedIn and BlueSky!